This session will look at the development of a vaccine for COVID-19 and what cooperation is needed to fight the virus. More broadly it will examine the way in which bio-medical engineering and the healthcare sector is meeting the needs of changing demographics and creating a better future for the world’s citizens.[vc_quotes layout=”accordion” quotes=”%5B%7B%22name%22%3A%22Dr%20Ian%20Norton%22%2C%22job_role%22%3A%22Founder%20and%20managing%20director%2C%20Respond%20Global%3B%20former%20global%20head%20of%20WHO%E2%80%99s%20Emergency%20Medical%20Team%20Initiative%20(Australia)%22%2C%22content%22%3A%22Dr%20Ian%20Norton%2C%20founder%20and%20managing%20director%20of%20Respond%20Global%2C%20is%20a%20specialist%20emergency%20physician%20and%20an%20expert%20in%20coordinating%20emergency%20health%20responses%20to%20disease%20outbreaks%20and%20disasters.%5Cn%5CnNorton%20was%20head%20of%20the%20WHO%E2%80%99s%20Emergency%20Medical%20Team%20(EMT)%20Initiative%20in%20Geneva%20from%202014-20.%20During%20this%20time%2C%20he%20led%20responses%20to%20Ebola%2C%20Diphtheria%20and%20Measles%20outbreaks%20as%20well%20as%20to%20earthquakes%2C%20cyclones%2C%20and%20war%20zones.%5Cn%5CnPrevious%20to%20the%20WHO%2C%20he%20led%20the%20creation%20of%20disaster%20response%20teams%20in%20Australia%20and%20was%20the%20director%20of%20Disaster%20Preparedness%20and%20Response%20at%20the%20National%20Critical%20Care%20%26%20Trauma%20Response%20Centre%20(NCCTRC)%20in%20Darwin.%20Norton%20established%20the%20Australian%20Medical%20Assistance%20Teams%20(AUSMAT)%20framework%20and%20designed%20the%20field%20hospitals%20that%20are%20today%20used%20for%20international%20disaster%20and%20infectious%20disease%20responses.%20%5Cn%5CnHe%20established%20Respond%20Global%20in%20early%202020%20with%20the%20aim%20of%20empowering%20others%20to%20be%20able%20to%20plan%2C%20prepare%20and%20respond%20to%20health%20emergencies%20in%20their%20own%20countries.%20He%20and%20his%20team%20are%20currently%20assisting%20numerous%20organisations%20during%20the%20COVID%20pandemic%2C%20providing%20strategic%20and%20practical%20operational%20support%20about%20how%20to%20be%20COVID-Safe%20now%20and%20into%20the%20future.%22%2C%22image%22%3A%2235220%22%2C%22linkedin%22%3A%22https%3A%2F%2Fwww.linkedin.com%2Fin%2Fian-norton-8081241a1%2F%3ForiginalSubdomain%3Dau%22%7D%2C%7B%22name%22%3A%22Kari%20Stoever%22%2C%22job_role%22%3A%22Chief%20external%20relations%20officer%2C%20On%20Demand%20Pharmaceuticals%20(United%20States)%22%2C%22content%22%3A%22Kari%20Stoever%20is%20a%20global%20development%20and%20health%20policy%20expert%20with%20more%20than%2020%20years%20of%20experience%20in%20health%20start-ups.%20%20Currently%20she%20is%20the%20chief%20external%20relations%20officer%20at%20On%20Demand%20Pharmaceuticals%2C%20an%20innovative%20pharmaceutical%20manufacturing%20company%20transforming%20how%20medicines%20are%20made%20so%20they%20can%20be%20produced%20on%20demand%20whenever%20and%20wherever%20medicines%20are%20needed.%5CnPreviously%2C%20she%20served%20as%20the%20chief%20external%20relations%20at%20the%20Lieber%20Institute%20for%20Brain%20Development%2C%20a%20nonprofit%20biotech%20developing%20next%20generation%20cures%20for%20brain%20disorders.%20%20While%20working%20at%20the%20Nike%20Foundation%20she%20led%20a%20%24210%20million%20partnership%20between%20the%20President%E2%80%99s%20Emergency%20Plan%20for%20AIDS%20Relief%20(PEPFAR)%20and%20the%20Gates%20Foundation%20to%20reduce%20new%20HIV%20infections%20in%20adolescent%20girls%20and%20young%20women.%20%20She%20was%20also%20part%20of%20a%20President%20Obama%E2%80%99s%20task%20force%20who%20designed%20SPARK%2C%20a%20common%20symbol%20and%20platform%20for%20connecting%20diverse%20programs%20working%20to%20promote%20entrepreneurship%20around%20the%20world.%20%20The%20programs%20selected%20to%20the%20President’s%20Spark%20Initiative%20represent%20the%20best%20work%20being%20done%20by%20the%20U.S.%20Government%20to%20advance%20entrepreneurship%20around%20the%20world.%5Cn%20%5CnWhile%20at%20Aeras%2C%20a%20global%20nonprofit%20biotech%20developing%20next%20generation%20tuberculosis%20vaccine%2C%20she%20led%20an%20initiative%20with%20the%20European%20Commission%20and%20European%20Investment%20Bank%20to%20design%20the%20world%E2%80%99s%20first%20blended%20capital%20fund%20to%20support%20infectious%20disease%20R%26D.%20%20Prior%20to%20Aeras%20she%20was%20the%20President%20and%20Founder%20of%20Meliora%20Global%2C%20LLC%2C%20firm%20focused%20on%20growth%20strategies%20for%20nonprofits%20and%20social%20ventures%2C%20helping%20clients%20build%20multi-sector%20collaborative%20partnerships%20to%20achieve%20their%20local%2C%20regional%20or%20global%20goals.%20%20%20%5CnMeliora%20Global%20clients%20included%20Pegasus%20Capital%20Advisors%2C%20Ashoka%2C%20the%20United%20Nations%20Special%20Envoy%E2%80%99s%20office%20for%20Malaria%2C%20Grameen%20(Nobel%20Peace%20Prize%20winner%2C%20Professor%20Mohammad%20Yunus)%20on%20the%20development%20of%20social%20businesses%2C%20and%20the%20African%20Program%20for%20Onchocerciasis%20Control.%20%5CnWhile%20at%20the%20Sabin%20Institute%2C%20she%20helped%20establish%20and%20was%20the%20managing%20director%20of%20the%20Global%20Network%20for%20Neglected%20Tropical%20Diseases%20(NTD).%20She%20was%20the%20Principal%20Investigator%20on%20a%20%2434%20million%20grant%20by%20the%20Bill%20%26%20Melinda%20Gates%20Foundation%20to%20establish%20regional%20financing%20mechanisms%20and%20to%20increase%20international%20investments%20for%20the%20scale-up%20of%20NTD%20control%20and%20elimination%20strategies%20globally.%20Under%20her%20leadership%2C%20the%20Global%20Network%20secured%20more%20than%20US%20%24100%20million%20in%20grants%20and%20financial%20commitments%20and%20led%20the%20development%20of%20a%20U.S.%20government%20%241%20billion%2C%205-year%20strategy%20for%20NTDs.%20%5CnPrior%20to%20her%20work%20at%20Sabin%2C%20she%20spent%20several%20years%20managing%20clinical%20research%20studies%20in%20cancer%20and%20infectious%20diseases.%20She%20spent%20a%20year%20working%20for%20the%20Department%20of%20Defense%20at%20the%20United%20States%20Army%20Medical%20Research%20Institute%20for%20infectious%20diseases%20(USAMRIID)%20managing%20anthrax%20and%20other%20biodefense%20studies.%5CnShe%20is%20the%20author%20of%20a%20book%20chapter%20%E2%80%98Governance%20Models%20for%20Eradication%20Initiatives%E2%80%99%20and%20a%20co-author%20on%20%E2%80%98Elements%20of%20Good%20Governance%20in%20Disease%20Eradication%20Initiatives%E2%80%99%20in%3A%20%20Disease%20Eradication%20in%20the%2021st%20Century%3A%20Implications%20for%20Global%20Health%3B%20Cochi%2C%20Stephen%20L.%2C%20and%20Walter%20R.%20Dowdle%2C%20editors.%202011.%20Str%C3%BCngmann%20Forum%20Report%2C%20vol.%207.%20Cambridge%2C%20MA%3A%20MIT%20Press.%5CnIn%202010%20she%20received%20the%20distinguished%20Stevie%20Award%20for%20Women%20in%20Business%20-%20Best%20Executive%20%E2%80%93%20Service%20Businesses%20%E2%80%93%20up%20to%202%2C500%20employees.%20%20She%20has%20served%20on%20the%20board%20of%20the%20Women%E2%80%99s%20Leadership%20Initiative%20at%20Georgetown%20University%E2%80%99s%20McDonough%20School%20of%20Business%2C%20and%20was%20the%20Chairperson%20to%20Invisible%20Children%2C%20an%20organization%20dedicated%20to%20raising%20awareness%20and%20mobilizing%20support%20to%20end%20the%20Lord%20Resistance%20Army%E2%80%99s%20atrocities%20in%20Central%20Africa.%20%5CnShe%20holds%20a%20B.Sc.%20from%20George%20Washington%20University%2C%20a%20degree%20in%20nursing%2C%20and%20an%20Executive%20Masters%20in%20Leadership%20from%20the%20McDonough%20School%20of%20Business%2C%20Georgetown%20University.%20%22%2C%22image%22%3A%2235285%22%2C%22linkedin%22%3A%22https%3A%2F%2Fwww.linkedin.com%2Fin%2Fkari-stoever-791a914%2F%22%7D%5D” title=”Speakers” el_class=””][vc_quotes layout=”accordion” quotes=”%5B%7B%22name%22%3A%22Colin%20Tate%22%2C%22job_role%22%3A%22Chief%20executive%2C%20Conexus%20Financial%20(Australia)%22%2C%22content%22%3A%22Colin%20Tate%20has%20been%20an%20investment%20industry%20media%20publisher%20and%20conference%20producer%20since%201996.%20In%20his%20media%20career%2C%20Tate%20has%20launched%20and%20overseen%20dozens%20of%20print%20and%20electronic%20publications.%20He%20is%20the%20chief%20executive%20and%20major%20shareholder%20of%20Conexus%20Financial%2C%20which%20was%20formed%20in%202005%2C%20and%20is%20headquartered%20in%20Sydney%2C%20Australia.%20The%20company%20stages%20more%20than%2020%20conferences%20and%20events%20each%20year%20%E2%80%93%20in%20London%2C%20New%20York%2C%20San%20Francisco%2C%20Los%20Angeles%2C%20Amsterdam%2C%20Beijing%2C%20Sydney%20and%20Melbourne%20%E2%80%93%20and%20publishes%20five%20media%20brands%2C%20including%20the%20global%20website%20and%20strategy%20newsletter%20for%20global%20institutional%20investors%20conexust1f.flywheelstaging.com.%20One%20of%20the%20company%E2%80%99s%20signature%20events%20is%20the%20bi-annual%20Fiduciary%20Investors%20Symposium.%20Conexus%20Financial%E2%80%99s%20events%20aim%20to%20place%20the%20responsibilities%20of%20investors%20in%20wider%20societal%2C%20and%20political%20contexts%2C%20as%20well%20as%20promote%20the%20long-term%20stability%20of%20markets%20and%20sustainable%20retirement%20incomes.%20Tate%20served%20for%20seven%20years%20on%20the%20board%20of%20Australia%E2%80%99s%20most%20high%20profile%20homeless%20charity%2C%20The%20Wayside%20Chapel%3B%20and%20he%20has%20underwritten%20the%20welfare%20of%2060%2C000%20people%20in%2028%20villages%20throughout%20Uganda%20via%20The%20Hunger%20Project.%22%2C%22image%22%3A%2231893%22%2C%22linkedin%22%3A%22https%3A%2F%2Fwww.linkedin.com%2Fin%2Fcolin-tate-839a5a181%2F%22%7D%5D” title=”Moderator” el_class=””][vc_empty_space height=”10px”]
Key takeaways
Kari
The vaccine progress to date has been nothing short of heroic, but the equitable manufacture and distribution of the vaccine is now the hardest part and must be needs based.
The most important thing in the first instance is to get the vaccine to the most vulnerable.
The risk of accelerated vaccine production and distribution is a risk worth taking. The existing vaccines are potent.
We need to work both bottom up and top down but in the USA we have seen a failure at both levels.
You cannot mandate human behaviour so we need a lot more education on why health rules are in place.
A lot of the claims made regarding COVID safety are worrying.
It is dangerous for leaders to suggest that individual rights are more important than public health.
COVID has forced us to supercharge technological innovation and that positive trajectory is likely to continue.
COVID will force domestic vaccine manufacturing capabilities to be strengthened.
Coldchain logistics will be an interesting area for the future. Perhaps going forward vaccines will not need to be stored at negative 80. Storage at negative 80 is unlikely to be achieved at scale in Africa.
We need a social safety net in place so that people are not choosing between staying at home not working or working whilst placing themselves and others at risk.
This is not the last pandemic we will see.
Dr Ian
Our leaders cannot simply lead by command, they must walk with the people.
Different to Ebola, COVID has led to an infodemic – an outbreak of alternate views, which are truly hard to manage in a health sense.
The vaccine is all about supply chain, logistics and sheer scale. Proactive testing for example demands an enormous amount of supply.
Make no mistake, vaccination will be a slow process – A sign of success for Africa would be 20% of the continent to be vaccinated by the end of 2021. We have never seen a pandemic end in less than 2-3 years. There will be several waves to come.
We need an agency like the WHO but unless we invest in it sufficiently and give it flexibility to use funds as it deems fit then we will not have the agency we need. If we didn’t have a WHO we would have to invent one. In the next 3 years, more criticism of the WHO will follow. The future of global health management could involve blocks of countries coming together to drive impact at scale.
We have all learned that a healthy workforce is a productive workforce.
We are likely to see a rebound of funding back into neglected health issues such as cancer and trauma care.
Ethically minded businesses will grow massively going forward.
There are clear implications for the management of investment portfolios. The world may only return to a resemblance of ‘normal’ earliest 2023 mostly due to the challenges presented by Africa and Central / South East Asia. Central and South America may only recover by around 2022.
APG's CIO Peter Branner explains how the pandemic has accelerated key trends already underway around digitization, central bank policy and action to combat climate change. It all points to fierce competition for private assets.
Nigel Topping who was appointed by the UK Government as the High Level Climate Action Champion for United Nations climate talks, COP26 joins Fiona Reynolds, chief executive of the PRI, in conversation with Amanda White, editor of Top1000funds.com This episode focuses on climate change and how, amongst and despite, the short-term focus of this COVID-19 crisis, we can mobilise government, business and investors into action around this important issue of climate change.
Political regimes around the world are stuck in a series of dead-ends and despair. Most importantly, the China-US relationship has hit a brick wall as their fundamentally different values and interests clash. Deterrents and robust policy is the only way forward, says Stephen Kotkin, professor in history and international affairs, Princeton University.
Singapore’s sovereign wealth fund GIC and PGIM, one of the world’s largest asset managers, have collaborated to develop a world-first asset allocation framework that explicitly models the impact of private assets on total portfolio liquidity, incorporating both the top-down allocation view and the bottom-up cash flow view.
In this Fiduciary Investors Series podcast Amanda White talks to Henry Richards, who is the project lead on the Future of the Corporation at the British Academy. The discussion is part of our exploration of purposeful companies and the premise that we need to redefine business in the 21st century to build trust between corporations, investors and society.
Already OPTrust’s portfolio can best be described as resilient. But CIO James Davis, who started his career in October 1987, expects global macro economic changes from this crisis that we have never seen before and he wants to position the portfolio for whatever is around the corner.
Looking back at the portfolios of large institutional investors during and after the dot.com crash and the GFC, CEM Benchmarking, reveals commonality in the portfolios that thrived. For both events the top quartile returns were more than 2 per cent higher than the bottom quartile. Analysing the asset allocation and behaviour of investors showed two clear themes: top quartile performers had more defensive allocations pre-crash; and rebalancing is a tailwind for performance.
Leave a Comment
You must be logged in to post a comment.
Login